Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704544 | SCV000534033 | likely benign | not provided | 2019-12-26 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV001170160 | SCV001332710 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-10-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001449119 | SCV001652224 | likely benign | Adams-Oliver syndrome 5 | 2024-06-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001449119 | SCV002554953 | likely benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270458 | SCV002554955 | likely benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001170160 | SCV002737435 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |